GATA3 and neoplasm: Spatial heterogeneity was identified in all five BBCs, with almost all heterogeneous mutations between bilateral tumor lesion (range: 95.4–100%), except for only one ubiquitous mutation GATA3 in patient P03 (Figure 2A).